View Archive: 2010  |  2009  |  2008  |  2007  |  2006  |  2005  |  2004  |  2003  |  2002  |  2001  |  2000  |  1999  |  1998

December 14, 2005
Cytokinetics Announces Seven Poster Presentations at the 45th Annual American Society of Cell Biology Meeting

December 13, 2005
Cytokinetics Announces Selection of Development Candidate Directed to Second Mitotic Kinesin Target

December 8, 2005
Cytokinetics Announces Presentation of Ispinesib data at San Antonio Breast Cancer Symposium

December 7, 2005
Cytokinetics Announces Selection of CK-1827452 as Development Candidate for Chronic Heart Failure

December 7, 2005
Cytokinetics Announces Seven Posters to be Presented at the 45th Annual American Society of Cell Biology Meeting

December 2, 2005
Cytokinetics Sponsors Fourth Special Interest Subgroup on Function and Regulation of Actin-Myosin Interactions

December 1, 2005
Cytokinetics Announces Interim Phase II Breast Cancer data for Ispinesib to be presented at San Antonio Breast Cancer Symposium

November 22, 2005
Cytokinetics to Present at the Lazard Capital Markets Life Sciences Conference

November 17, 2005
Cytokinetics Announces Clinical and Non-Clinical Results for Ispinesib at the 2005 Annual AACR-NCI-EORTC Meeting

November 11, 2005
Cytokinetics to Present at the Credit Suisse First Boston Health Care Conference

November 10, 2005
Cytokinetics Announces Clinical and Non-Clinical Data on Ispinesib to be Presented at the 2005 AACR-NCI-EORTC International Meeting

October 31, 2005
Cytokinetics to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference

October 28, 2005
Cytokinetics Secures $75 Million Committed Equity Financing Facility

October 26, 2005
Cytokinetics, Incorporated Reports Third quarter 2005 Financial Results

October 19, 2005
Cytokinetics to Announce Third Quarter Results on October 26, 2005

October 12, 2005
Cytokinetics to Present at BIO InvestorForum 2005

September 27, 2005
Cytokinetics Provides Clinical Trials Update for Ispinesib (SB-715992)

September 27, 2005
Cytokinetics and GlaxoSmithKline Amend Collaboration Agreement for SB-743921

September 19, 2005
Cytokinetics presents Data on CK-1827452 at the 2005 Annual Heart Failure Society of America Meeting

September 12, 2005
Cytokinetics To Present Non-Clinical Data on CK-1827452 at the 2005 Annual Heart Failure Society of America Meeting

September 6, 2005
Cytokinetics to Present at the Bear Stearns 18th Annual Healthcare Conference

September 6, 2005
Cytokinetics Announces the Initiation of a Phase I Clinical Trial of CK-1827452 for the Treatment of Acute Heart Failure

September 2, 2005
Cytokinetics to Present at the 12th Annual NewsMakers in the Biotech Industry Conference

July 27, 2005
Cytokinetics, Incorporated Reports Second Quarter 2005 Financial Results

July 27, 2005
Cytokinetics Presents Data From Heart Failure Program

July 20, 2005
Cytokinetics to Announce Second Quarter Results on July 27, 2005

June 14, 2005
Cytokinetics Files Shelf Registration Statement

June 7, 2005
Cytokinetics to Present at the Goldman Sachs Twenty-Sixth Annual Global Healthcare Conference

May 27, 2005
Cytokinetics to Present at the Pacific Growth Equities 2005 Life Sciences Growth Conference

May 25, 2005
Cytokinetics to Present at the Friedman Billings Ramsey 9th Annual Growth Investor Conference

May 18, 2005
Cytokinetics to Present at the Needham & Company Fourth Annual Biotechnology Conference

May 14, 2005
Cytokinetics Announces Interim Phase I Results for SB-743921 at the 2005 Annual Meeting of The American Society of Clinical Oncology

May 12, 2005
Cytokinetics to Hold Annual Meeting of Stockholders

May 10, 2005
Cytokinetics to Present at the Banc of America Securities Health Care Conference 2005

April 27, 2005
Cytokinetics, Incorporated Reports First Quarter 2005 Financial Results

April 25, 2005
Cytokinetics to Present at the Deutsche Bank 30th Annual Health Care Conference

April 20, 2005
Cytokinetics to Announce First Quarter Results on April 27, 2005

April 5, 2005
Cytokinetics Announces Changes to Board of Directors

April 5, 2005
Cytokinetics Announces Interim Phase I Results for SB-743921 to be Presented at the 2005 Annual Meeting Of The American Society of Clinical Oncology

March 31, 2005
Cytokinetics to Present at the BioCentury Future Leaders in the Biotech Industry Conference

March 3, 2005
Cytokinetics Announces Selection of Heart Failure Drug Development Candidate

February 16, 2005
Cytokinetics to Present at the BIO CEO & Investor Conference 2005

February 3, 2005
Cytokinetics, Incorporated Reports Fourth Quarter and Year End 2004 Financial Results

January 27, 2005
Cytokinetics to Release Fourth Quarter and Year End 2004 Financial Results on February 3, 2005